Eletriptan (trade name Relpax, used in the form of eletriptan hydrobromide) is a second generation triptan drug intended for treatment of migraine headaches. It is used as an abortive medication, blocking a migraine attack which is already in progress. Eletriptan is marketed and manufactured by Pfizer Inc. It is sold in the US and Canada under the brand name Relpax, and in several other countries under the brand name Relert.

CAS：143322-58-1
中文别名：氢溴酸依利曲坦;3-苄基-5-(1-(2-(吡咯烷-1-基)乙基)-1H-吲哚-3-基)-1,2,4-恶二唑;3-[(1-甲基吡咯烷-2-基)甲基]-5-(2-苯基磺酰乙基)-1H-吲哚;
英文别名：Eletriptan;5-[2-(benzenesulfonyl)ethyl]-3-[[(2R)-1-methylpyrrolidin-2-yl]methyl]-1H-indole;
分子式：C22H26N2O2S
分子量：382.519
精确质量：382.171
Psa：61.55
Logp：4.8397

外观与性状：黄色泡沫
密度：1.235 g/cm3
沸点：613.4ºC at 760 mmHg
闪点：324.8ºC
蒸汽压：1.58E-16mmHg at 25°C